The semaglutide maximum dose is 2.4 mg weekly for Wegovy, 2 mg weekly for Ozempic, and 14 mg daily for Rybelsus. Learn how U.S. dosing works.
The maximum FDA-approved dose of semaglutide depends on the product: Wegovy tops out at 2.4 mg once weekly for weight management, Ozempic at 2 mg once weekly for type 2 diabetes, and Rybelsus at 14 mg once daily for type 2 diabetes. If you're asking what is the maximum dose of semaglutide, the answer is not a single number—it varies by brand, form, and treatment goal. Your prescriber will choose the right ceiling based on your medical history and treatment target.
FDA-Approved Maximum Doses by Product
Semaglutide is sold under several brand names, and each has its own dosing ceiling. The table below summarizes the approved semaglutide max dose for adults in the United States.
| Product | Form | Approved Use | Starting Dose | Maximum Approved Dose | Frequency |
|---|---|---|---|---|---|
| Ozempic | Injection | Type 2 diabetes | 0.25 mg | 2 mg | Once weekly |
| Wegovy | Injection | Weight management | 0.25 mg | 2.4 mg | Once weekly |
| Rybelsus | Oral tablet | Type 2 diabetes | 3 mg | 14 mg | Once daily |
Key conclusion: Wegovy 2.4 mg weekly is the highest FDA-approved dose of semaglutide for weight loss in the United States.
Ozempic and Wegovy are not interchangeable without a clinician's guidance, even though they contain the same active ingredient. The maximum dose for one product is not automatically safe or effective for the other. Your prescriber will choose the product and dose based on your medical history and treatment goals.
Why the Maximum Dose Differs by Treatment Goal
Weight loss and blood sugar control are different medical goals, and they respond to different dose ranges. Clinical trials for obesity used higher weekly doses than trials for type 2 diabetes. That is why the semaglutide highest dose for weight management is 2.4 mg, while the maximum for diabetes is lower.
Dose-response studies show that higher semaglutide doses generally produce more weight loss, but they also increase the risk of gastrointestinal side effects. Researchers and clinicians often explain why increase dose of semaglutide for weight loss by pointing to this trade-off: more benefit, but also more nausea, vomiting, and diarrhea for some people.
For type 2 diabetes, the goal is to lower blood sugar safely over time. A lower dose may be enough to reach target A1C levels, so pushing to the maximum is not always necessary. For obesity, the goal is a certain percentage of weight loss, which may require a higher dose.
How Semaglutide Dosing and Titration Work
Semaglutide is not started at its maximum dose. Clinicians use a stepwise approach called titration to reduce side effects. The starting dose of semaglutide for weight loss is 0.25 mg once weekly, a dose that is not intended to produce meaningful weight loss but to let the body adjust.
After four weeks, the dose typically increases to 0.5 mg weekly, then to 1 mg, 1.7 mg, and finally 2.4 mg if tolerated. Each step usually lasts at least four weeks. If side effects are severe, a clinician may slow the titration or keep the dose lower.
Some people never reach the maximum dose because they achieve their goals or cannot tolerate higher amounts. The best dose is the lowest one that safely helps you meet your treatment target.
Oral Semaglutide and Higher-Dose Research
Oral semaglutide (Rybelsus) is currently approved only for type 2 diabetes at a maximum of 14 mg daily. The semaglutide tablet dose for weight loss is not yet approved in the United States, though higher oral doses (25 mg and 50 mg) have been studied in obesity trials.
Researchers are also testing injectable semaglutide at 7.2 mg weekly, which is three times the current Wegovy maximum. This investigational dose is not FDA-approved, and it should not be used outside a clinical trial.
Combination therapies are another active area. A fixed-dose combination of cagrilintide and semaglutide is in late-stage trials for obesity, and it may eventually offer an alternative to current maximum doses. Until then, the approved maximums remain the standard of care.
Safety and Side Effects at Higher Doses
Higher semaglutide doses are associated with more frequent and more intense side effects. The most common are nausea, vomiting, diarrhea, constipation, and abdominal pain. These symptoms often improve after a few weeks, but they can be severe enough to require medical attention.
More serious risks include pancreatitis, gallbladder disease, kidney injury from dehydration, and hypoglycemia when semaglutide is combined with insulin or sulfonylureas. Semaglutide also carries a boxed warning about thyroid C-cell tumors observed in rodents; the relevance to humans is not fully established.
If you miss a dose, side effects can sometimes worsen when you restart at a higher dose. A clinician may suggest a semaglutide maintenance dose every other week for people who cannot tolerate the standard weekly schedule, but this is an off-label strategy and requires close monitoring.
Key conclusion: Never increase your semaglutide dose without talking to a healthcare professional, even if you have tolerated higher doses in the past.
What to Discuss With Your Prescriber
Before aiming for the semaglutide maximum dose, ask your prescriber about your individual risks, goals, and alternatives. Bring a list of all medications and supplements, because semaglutide can interact with other treatments.
Pregnancy, breastfeeding, a history of pancreatitis, and certain kidney or eye conditions may make semaglutide inappropriate for you. Your clinician can help you weigh the benefits of a higher dose against the risks.
Semaglutide is a prescription medicine, and the FDA-approved maximum doses are based on large clinical trials. Compounded semaglutide products are not FDA-approved and may contain different amounts of the active ingredient than the labeled product.
Key conclusion: The FDA-approved maximum dose of semaglutide is 2.4 mg weekly for Wegovy, 2 mg weekly for Ozempic, and 14 mg daily for Rybelsus.
Frequently Asked Questions
What is the maximum dose of semaglutide for weight loss?
The maximum FDA-approved dose of semaglutide for weight loss is 2.4 mg once weekly, which is the top dose of Wegovy. This dose is reached after a gradual titration that usually takes at least 16 weeks. Higher doses, such as 7.2 mg weekly, are investigational and not approved.
Can you take more than 2.4 mg of semaglutide?
No, taking more than 2.4 mg of semaglutide weekly is not FDA-approved for any product. Clinical trials have studied 7.2 mg weekly for obesity, but that dose is not available by prescription. Using more than the approved maximum increases the risk of severe nausea, vomiting, and other complications.
What happens if you accidentally take too much semaglutide?
An overdose of semaglutide can cause severe nausea, vomiting, diarrhea, abdominal pain, and dehydration. It may also lead to hypoglycemia if you take insulin or a sulfonylurea. Seek immediate medical attention if you experience persistent vomiting, severe weakness, or signs of dehydration.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.